Urothelial carcinoma in COVID-19: lessons from a pandemic and their impact on clinical practice

The COVID-19 pandemic has modified the management of urothelial carcinoma (UC). Eighteen months after the onset of the pandemic, a scoping narrative review was able to state that radical cystectomy for UC should not be delayed beyond 10 weeks when neoadjuvant chemotherapy (NAC) was administered and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tayeh, Georges Abi, Khalil, Nour, Alkassis, Marwan, Aoun, Fouad, Waked, Chady, Nemr, Elie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547276/
https://www.ncbi.nlm.nih.gov/pubmed/34672692
http://dx.doi.org/10.2217/fon-2021-0895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547276/
https://www.ncbi.nlm.nih.gov/pubmed/34672692
http://dx.doi.org/10.2217/fon-2021-0895

Ejemplares similares